Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Clinical Trial ID NCT00186628

PubWeight™ 1.33‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00186628

Top papers

Rank Title Journal Year PubWeight™‹?›
1 National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005 19.83
2 Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood 2012 1.31
Next 100